Navigation Links
Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
Date:9/7/2012

nding.  We may determine such a dose based on an efficacy signal or an acceptable safety profile in the Phase 1b trial and/or upon calculating it from ongoing PET imaging trials in cancer patients with LIGHT (since PET imaging is quantitative, enabling determination of tumor radiation exposure at a given dose level).  Preclinical experiments in vitro (in cell culture) and in more than a dozen in vivo (in animals) models have demonstrated selective killing of cancer cells along with a benign safety profile.  In view of HOT's selective uptake and retention in a wide range of solid tumors and in cancer stem cells, its single-agent efficacy in animal models and its non-specific mechanism of cancer-killing (radiation), we are first developing HOT as a monotherapy for solid tumors with significant unmet medical need.

About Novelos Therapeutics, Inc.
We are a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer.  Our cancer-targeted compounds are selectively taken up and retained in cancer cells, including cancer stem cells, versus normal cells.  Thus, our therapeutic compounds appear to directly kill cancer cells while minimizing harm to normal cells.  This offers the potential for a paradigm shift in cancer therapy by providing efficacy versus all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse.  I-124-CLR1404 (LIGHT) is a small-molecule cancer-targeted PET imaging agent.  We believe LIGHT has first-in-class potential and Phase 1-2 clinical trials are ongoing across 11 solid tumor indications.  I-131-CLR1404 (HOT) is a small-molecule, broad-spectrum, cancer-targeted molecular radiotherapeutic that delivers cytotoxic radiation directly and selectively to cancer cells and cancer stem cells.  We believe HOT also has first-in-class potential.  HOT Phase 1b dose-escalation trial is ongoing and we expect HOT to en
'/>"/>

SOURCE Novelos Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Novelos Therapeutics Prices $5.4 Million Public Offering
4. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
5. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
6. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
8. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
9. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... The Physician-Patient Alliance for Health & Safety recently released three ... urgently address this issue has been emphasized by The ... device alarm safety in hospitals." According to The Joint Commission ... there were 98 alarm related events reported, of which: ... resulted in permanent loss of function (13%) , 5 ...
(Date:6/19/2013)... Calif. , June 19, 2013  Finesse ... solutions for life sciences process applications, announced the ... bioreactors for upstream cell culture and fermentation.  The ... new product family of Finesse bioreactors and are ... cGMP applications.  They are fully compatible with all ...
(Date:6/19/2013)...   Voices Against Brain Cancer (VABC), a ... cancer, today announced that it has awarded Tocagen Inc. ... investigation of Toca 511 & Toca FC in patients ... (Grade 3 or Grade 4).  Tocagen is a privately ... with an initial focus on brain cancer. ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
... MINNEAPOLIS and HUDIKSVALL, Sweden, Oct. 6 Nonin ... manufacturing center, formerly MedAir AB, has changed its ... operations to better serve Nonin Medical,s European customers ... and service Nonin,s European capnography products, Nonin Medical ...
... Scripts (Nasdaq: ESRX ) has completed the ... a new independent, nonprofit charitable organization with the mission ... Americans and working families. Michael Holmes, ... new national organization, which has its headquarters in St. ...
Cached Medicine Technology:Nonin Medical, Inc. Announces Capnography Division Name Change; Expands Swedish Manufacturing Facility to Become Full-Franchise European Sales, Distribution and Service Center 2Express Scripts Completes Spinoff of Rx Outreach 2
(Date:6/20/2013)... 2013 Anant Goel, CEO at RKNet ... empower children and adults with skills of the 21st Century ... form the foundation for success in the new millennium. Everyone ... access to technology does not automatically make us the master ... work, businesses, and life." , The following ...
(Date:6/20/2013)... TX (PRWEB) June 20, 2013 ... maintained a wide range of outpatient and inpatient mental ... issues, including those who are children. As a facility ... explains that it is critical to diagnose mental health ... However, according to a recent article from ...
(Date:6/20/2013)... NJ (PRWEB) June 20, 2013 As ... is volunteer assistance. Keeping volunteers motivated in a non-profit ... Kars4Kids , a the nation’s leading car donation charity ... network of over 1,000 individuals, has announced the best ... not only physically present, but mentally engaged as well. ...
(Date:6/20/2013)... Businesses which are failing to be savvy where ... in the tidal wave of competition, warns Australia's leading business ... 50 Tips Collected from the Top Blogs is available ... to listen to the social media pros. This is because ... since its onset and they, more than most PR pros ...
(Date:6/20/2013)... Dorset (PRWEB) June 20, 2013 Millions ... and more serious medical conditions because they do not ... Eludril mouthwash and Elgydium toothpaste. , Seven million Britons ... it 48 hours between brushes, latest data from the ... cent of people polled by the BDHF also admitted ...
Breaking Medicine News(10 mins):Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 2Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 3Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 2Health News:New Statistics Indicate Increase in Mental Health Issues Among Children, UBH Denton Responds 3Health News:Kars4kids Announces Tips on How to Keep Non-profit Volunteers Engaged, Passionate and Active 2Health News:Social Media Marketing: Casey Gollan's Round-up of Tips from the Top Blogs 2Health News:Social Media Marketing: Casey Gollan's Round-up of Tips from the Top Blogs 3Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 2Health News:Millions Are Risking Gum Disease, Warn Eludril And Elgydium 3
... restriction seems to be the key to extend the ... ,Researchers from Harvard Medical School, Boston and University of ... lifespan via Sir2 gene. According to the study published ... and Drosophila lacking the Sir2 gene do not live ...
... Research and Lviv Regional Oncology center//, Ukraine has developed ... detection of breast and ovarian cancer. ,However, they ... "Attempts to find a single reliable early protein, or ... been very successful," says LICR's Serhiy Souchelnytskyi, senior author ...
... of Mayo Clinic have found the cause of chronic sinus ... infected and not the nasal and sinus tissue. The findings ... Allergy and Clinical Immunology. ,Researchers fro the study report ... the diseased airway tissue is not valid anymore, as their ...
... time and again thought ways to deter their toddlers// from ... channels, but how many are right for viewing by children. ... adding parents is a scientific that can help them justify ... educational purposes, it harms the cognitive development. ,A ...
... investigating the mysterious death of a woman whose entire body ... ears in an ordeal that started with a simple fever, ... disbelief, the family of June Wong, 26, is demanding answers. ... , ,Wong is suspected of having Stevens-Johnson Syndrome, a severe ...
... want to know answers to everything. This gains special// importance ... often have we questioned the diseases that make our precious ... ,Researchers in a breakthrough have unraveled the mystery surrounding heart ... failure, the heart uses too much fatty acid and not ...
Cached Medicine News:Health News:Genes to Extend Longevity Discovered 2Health News:Molecular markers for early diagnosis of breast and ovarian cancer 2Health News:Chronic Sinusitis May Be Related To Nasal Mucus 2Health News:Stop Watching TV: Toddler Development Affected 2
... Oval-8 Ring Splints provide finger stability ... acute injuries, hypermobility, and loss of control ... splints are made from translucent, neutral-tone plastic ... The 3-point pressure design makes them the ...
... controlled stretch knee support that helps reduce ... range of motion. The medial and ... and help to keep the elastic material ... is an excellent support for post-surgical recovery. ...
... laminated to breathable foam. Three piece design ... straps with loop closures. Lightweight rigid posterior ... ,Available with optional hot and cold ... defeat the pain cycle by providing cold ...
... of the outstanding features of our Neomax ... Molding Technology. , This manufacturing process allows ... controls the bunching and irritation in the ... wearer. , ,Colors available: Blue, ...
Medicine Products: